Maeda Takuya 前田拓哉

Researcher Number	60979102
Other IDs
Affiliation (Current)	2025: 北海道大学, 医学研究院, 客員研究員
Affiliation (based on the past Project Information) *help	2023 – 2024: 北海道大学, 大学病院, 助教
Review Section/Research Field	Principal Investigator Basic Section 53050:Dermatology-related Except Principal Investigator Basic Section 53050:Dermatology-related
Keywords	Principal Investigator 逆説性発癌 / 扁平上皮癌 / 皮膚癌 Except Principal Investigator 皮膚癌 / 既存薬 / 核酸医薬 / 治療濃度 / 細胞周期 / 細胞死 / 薬剤スクリーニング / 血管肉腫

DNA合成阻害剤による逆説的発がん現象の解明と応用Principal Investigator
- Principal Investigator
  
  前田拓哉
- Project Period (FY)
  2024 – 2025
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 53050:Dermatology-related
- Research Institution
  Hokkaido University
Development of a novel therapeutic strategy for angiosarcoma through drug screening
- Principal Investigator
  
  中村秀樹
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53050:Dermatology-related
- Research Institution
  Hokkaido University

All 2024 2023

All Journal Article

[Journal Article] Clinical-histopathological features and cancer gene analysis of cutaneous epithelioid angiosarcoma: A report of 4 cases2024
- Author(s)
  Tokuchi Keiko、Yanagi Teruki、Kurosawa Suguru、Kitamura Shinya、Maeda Takuya、Hsu Che Yuan、Miyamoto Kodai、Nishihara Hiroshi、Ujiie Hideyuki
- Journal Title
  
  JAAD Case Reports
  
  Volume: 46 Pages: 45-48
- DOI
  10.1016/j.jdcr.2023.11.039
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K07757
[Journal Article] Eribulin for patients with metastatic extramammary Paget disease: Study protocol for a single‐arm phase II trial2023
- Author(s)
  Maeda Takuya、Yanagi Teruki、Tokuchi Keiko、Funakoshi Takeru、Horie Nao、Isoe Toshiyuki、Ito Yoichi M.、Sato Norihiro、Ujiie Hideyuki
- Journal Title
  
  Experimental Dermatology
  
  Volume: 33 Issue: 1
- DOI
  10.1111/exd.14993
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23K07757
[Journal Article] Eribulin inhibits growth of cutaneous squamous cell carcinoma cell lines and a novel patient-derived xenograft2023
- Author(s)
  Hsu Che-Yuan、Yanagi Teruki、Maeda Takuya、Nishihara Hiroshi、Miyamoto Kodai、Kitamura Shinya、Tokuchi Keiko、Ujiie Hideyuki
- Journal Title
  
  Scientific Reports
  
  Volume: 13 Issue: 1 Pages: 8650-8650
- DOI
  10.1038/s41598-023-35811-3
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K08397, KAKENHI-PROJECT-23K07757

1. 中村秀樹 (60435956)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
2. 柳輝希 (50755973)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
3. 氏家英之 (60374435)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
4. 西原広史

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Maeda Takuya 前田拓哉

Research Projects

Research Products

Co-Researchers

DNA合成阻害剤による逆説的発がん現象の解明と応用Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of a novel therapeutic strategy for angiosarcoma through drug screening

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Clinical-histopathological features and cancer gene analysis of cutaneous epithelioid angiosarcoma: A report of 4 cases2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Eribulin for patients with metastatic extramammary Paget disease: Study protocol for a single‐arm phase II trial2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Eribulin inhibits growth of cutaneous squamous cell carcinoma cell lines and a novel patient-derived xenograft2023

Author(s)

Journal Title

DOI

Data Source

Maeda Takuya 前田 拓哉

Research Projects

Research Products

Co-Researchers

DNA合成阻害剤による逆説的発がん現象の解明と応用Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of a novel therapeutic strategy for angiosarcoma through drug screening

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Clinical-histopathological features and cancer gene analysis of cutaneous epithelioid angiosarcoma: A report of 4 cases2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Eribulin for patients with metastatic extramammary Paget disease: Study protocol for a single‐arm phase II trial2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Eribulin inhibits growth of cutaneous squamous cell carcinoma cell lines and a novel patient-derived xenograft2023

Author(s)

Journal Title

DOI

Data Source

Maeda Takuya 前田拓哉